Home » Business, Health & Medicine, Manufacturing & Industry, Marketing & Sales, Professional Services » Generic Oncology Drug Market – Global Industry Analysis, Trends, Manufacturing Process, Income and Profits
“Generic Oncology Drug Market – Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue”
This report provides an insight into the cancer generics market and the requirements to setup and run a cancer generic drug manufacturing plant (both tablets and injectables). Factors such as capital cost, raw material requirements, machinery requirements, incomes, expenditures, etc. have been thoroughly analyzed in this report.

IMARC’s latest study “Generic Oncology Drug Market – Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report

Key Questions Answered in this Report?

  • What are the historical, current and future trends in the generic market?
  • What are the historical, current and future trends in the generic oncology market?
  • What is the competitive structure of the generic market and who are the key players?
  • What is the competitive structure of the generic oncology market and who are the key players?
  • What are the key success factors for generic oncology drug manufacturers?
  • How are generic oncology drugs manufactured?
  • What are the raw material requirements and their cost for manufacturing generic oncology drugs?
  • What are the land and construction requirements and their cost for manufacturing generic oncology drugs?
  • What are the machinery requirements and their cost for manufacturing generic oncology drugs?
  • What are the packaging requirements and their cost for manufacturing generic oncology drugs?
  • What are the utility requirements and their cost for manufacturing generic oncology drugs?
  • What are the manpower requirements and their cost for manufacturing generic oncology drugs?
  • What is the total capital investment required for setting up a generic oncology drug manufacturing plant
  • What are the operational costs for setting up a generic oncology drug manufacturing plant?
  • How much income will the generic oncology drug manufacturing plant generate?
  • What will be the profitability of the generic oncology drug manufacturing plant?
  • What will be the NPV of the generic oncology drug manufacturing plant?
  • What will be the payback period of the generic oncology drug manufacturing plant?

 

Table of Contents

1 Research Methodology
2 Report Summary
3 Introduction
4 Global Generic Drug Market
4.1 Classification of Generic Drugs
4.2 Market Trends
4.2.1 Current and Historical Market Trends
4.2.2 Market Breakup by Region
4.2.3 Major Players in the Generic Drug Industry
4.2.4 Market Forecast
4.3 Value Chain Analysis of Generic Drugs
4.4 Key Success Factors Driving the Generic Drug Industry
4.6 Regulations in the Generic Drug Industry
5 Global Cancer Generics Market
5.1 Global Cancer Statistics
5.2 Current and Historical Market Trends
5.3 Top Cancer Drugs
5.4 Top Players in the Cancer Generics Market
5.5 Market Forecast
6 Manufacturing Process
6.1 Detailed Process Flow (Tablet)
6.2 Detailed Process Flow (Injectables)
6.3 Cancer Generic Manufacturing Plant: Raw Material Requirements
6.3.1 Cancer Generic Drug (Tablet)
6.3.2 Cancer Generic Drug (Injectables)
7 Project Details, Requirements and Costs Involved
7.1 Land, Location and Site Development
7.2 Plant Machinery
7.3 Machinery Pictures
7.4 Raw Materials
7.5 Packaging
7.6 Utilities
7.7 Manpower
7.8 Other Capital Investments
8 Cancer Generic Drug Manufacturing Plant: Project Economics
8.1 Capital Cost of the Project
8.2 Loans and Financial Assistance
8.3 Techno-Economic Parameters
8.4 Product Pricing
8.5 Income Projections
8.6 Expenditure Projections
8.7 Financial Analysis

List of Figures

Figure 1 1: Global: Cancer Incidence: Breakup by Country (in %), 2015
Figure 4 1: Global: Generics Market: Sales Value (in US$ Billion), 2011-2015
Figure 4 2: Global: Generics Market: Breakup by Country (in %), 2015
Figure 4 3: Global: Generics Market: Sales Value (in US$ Billion), 2016-2021
Figure 4 4: Global: Generics Market: Value Chain
Figure 5 1: Global: Cancer Incidence: 2008-2015
Figure 5 2: Global: Cancer Incidence: Breakup by Country (in %), 2015
Figure 5 3: Global: Cancer Generics Market: Sales Value (in US$ Billion), 2008-2015
Figure 5 4: Global: Cancer Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020
Figure 6 1: Cancer Generic (Tablet) Manufacturing: Detailed Process Flow
Figure 6 2: Cancer Generic (Injectable) Manufacturing: Detailed Process Flow
Figure 6 3: Cancer Generic (Imatinib Tablet) Manufacturing Process: Conversion Rate of Feedstocks
Figure 6 4: Cancer Generic (Paclitaxel) Manufacturing Process: Conversion Rate of Feedstocks
Figure 7 1: Cancer Generic Manufacturing Plant: Primary Packaging
Figure 7 2: Cancer Generic Manufacturing Plant: Secondary Packaging
Figure 7 3: Cancer Generic Manufacturing Plant: Tertiary Packaging
Figure 8 1: Cancer Generic Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 8 2: Cancer Generic Manufacturing Plant: Breakup of Production Costs (in %)

List of Tables

Table 4 1: Global: Generics Market: Revenues of Key Players (in US$ Billion), 2015
Table 7 1: Cancer Generic Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 7 2: Cancer Generic Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 7 3: Cancer Generic Manufacturing Plant: Machinery Costs (in US$)
Table 7 4: Cancer Generic Manufacturing Plant: Raw Material Requirements (in Kg/Day)
Table 7 5: Cancer Generic Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 7 6: Cancer Generic Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 8 1: Cancer Generic Manufacturing Plant: Capital Costs (in US$)
Table 8 2: Details of Financial Assistance Offered by Financial Institutions
Table 8 3: Cancer Generic Manufacturing Plant: Loan Installments
Table 8 4: Cancer Generic Manufacturing Plant: Techno- Economic Parameters
Table 8 5: Cancer Generic Manufacturing Plant: Income Projections (in US$)
Table 8 6: Cancer Generic Manufacturing Plant: Expenditure Projections (in US$)
Table 8 7: Cancer Generic Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 8 8: Cancer Generic Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099 

IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:
Email:ema@imarcgroup.com
Phone: +44-702-409-7331 

To know more please visit: http://www.imarcgroup.com/generic-oncology-drug-manufacturing-plant


About IMARC Group

IMARC Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

To know more about our company, please visit: http://www.imarcgroup.com/

Media Contact
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email: sales@imarcgroup.com
Phone: +91-120-415-5099
Address:G B Nagar Noida Complex
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/

Comments are closed.